Wells Fargo Maintains Overweight on Tectonic Therapeutic, Lowers Price Target to $93

Benzinga Newsdesk www.benzinga.com Negative 89.8%

Neg 89.8% Neu 0% Pos 0%

Wells Fargo analyst Tiago Fauth maintains Tectonic Therapeutic (NASDAQ:TECX) with a Overweight and lowers the price target from $101 to $93.